J Aerosol Med Pulm Drug Deliv 2021 09 24;34(5):303-310. Epub 2021 Mar 24.
INSERM, Centre d'Étude des Pathologies Respiratoires (CEPR) UMR 1100, Université de Tours, Tours, France.
Obstructive patients may benefit from nasal high-flow (NHF) therapy, but the use of pressurized metered-dose inhalers (pMDIs) has not been evaluated in this situation. Using an adult circuit and medium-sized cannula, we have tested different NHF rates, pMDI positions, breathing patterns, spacers, and spacer orientation. First, we evaluated albuterol delivery at the nasal cannula outlet. Read More